dipyridamole has been researched along with Heart Failure in 65 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a randomized (2:1), double-blinded design study, we studied 25 patients with congestive heart failure (66 +/- 9 years, ejection fraction 30 +/- 7%) before and after 23-week treatment with the beta blocker carvedilol 25 mg twice daily (n = 17) or placebo (n = 8) in addition to standard therapy." | 9.10 | Effect of carvedilol on microcirculatory and glucose metabolic regulation in patients with congestive heart failure secondary to ischemic cardiomyopathy. ( Andreasen, F; Bøttcher, M; Gøtzsche, O; Nielsen, TT; Refsgaard, J, 2002) |
| "To assess whether dipyridamole therapy exerts a significant anti-inflammatory effect in heart failure patients." | 7.79 | Effect of concomitant oral chronic dipyridamole therapy on inflammatory cytokines in heart failure patients. ( Agrusta, M; Ambrosini, V; Del Ry, S; Giustarini, C; Morales, MA; Picano, E; Posteraro, F; Scali, MC; Sicari, R; Tafi, A, 2013) |
| "The effects of dipyridamole, a coronary and peripheral vasodilator drug, on cardiac performance were investigated in nine patients with severe chronic heart failure." | 7.66 | Central hemodynamic effects of dipyridamole in severe heart failure: comparison with hydralazine. ( Gorlin, R; Medina, N; Meller, J; Packer, M, 1982) |
| "Adenosine is well known to be a cardioprotective substance in ischemic heart disease." | 5.34 | Impact of adenosine receptor signaling and metabolism on pathophysiology in patients with chronic heart failure. ( Asakura, M; Asanuma, H; Fujita, M; Furukawa, H; Isomura, T; Kim, J; Kitakaze, M; Komamura, K; Liao, Y; Nakamaru, K; Tomoike, H, 2007) |
| "In a randomized (2:1), double-blinded design study, we studied 25 patients with congestive heart failure (66 +/- 9 years, ejection fraction 30 +/- 7%) before and after 23-week treatment with the beta blocker carvedilol 25 mg twice daily (n = 17) or placebo (n = 8) in addition to standard therapy." | 5.10 | Effect of carvedilol on microcirculatory and glucose metabolic regulation in patients with congestive heart failure secondary to ischemic cardiomyopathy. ( Andreasen, F; Bøttcher, M; Gøtzsche, O; Nielsen, TT; Refsgaard, J, 2002) |
| "The efficacy and safety of a combination of Persantine and aspirin, of aspirin alone and of a placebo as a regimen for preventing reinfarction were compared in 2026 patients who had recovered from a documented acute myocardial infarction (MI) that had occurred 8 weeks to 5 years previously." | 5.05 | The Persantine-aspirin reinfarction study. The Persantine-aspirin Reinfarction Study (PARIS) research group. ( , 1980) |
| " We retrospectively assessed the rate of SE positivity in 7626 SE tests (dipyridamole in 5053, dobutamine in 2496, exercise in 77) in consecutive patients with known or suspected coronary artery disease and /or heart failure who performed SE in a primary care referral center from April 1991 to May 2018." | 3.91 | Drop-off in positivity rate of stress echocardiography based on regional wall motion abnormalities over the last three decades. ( Bovenzi, F; Coltelli, M; Cortigiani, L; Picano, E; Ramirez, P, 2019) |
| "High-dose ASA in Heart Mate II patients treated concomitantly with warfarin is associated with an increased hazard of bleeding but does not reduce thrombotic events." | 3.83 | Antiplatelet Therapy and Adverse Hematologic Events During Heart Mate II Support. ( D'Alessandro, D; Goldstein, DJ; Guerrero, C; Jermyn, R; Jorde, UP; Kargoli, F; Levin, AP; Madan, S; Nguyen, J; Patel, SR; Saeed, O; Shah, A; Shin, J; Sims, DB, 2016) |
| "To assess whether dipyridamole therapy exerts a significant anti-inflammatory effect in heart failure patients." | 3.79 | Effect of concomitant oral chronic dipyridamole therapy on inflammatory cytokines in heart failure patients. ( Agrusta, M; Ambrosini, V; Del Ry, S; Giustarini, C; Morales, MA; Picano, E; Posteraro, F; Scali, MC; Sicari, R; Tafi, A, 2013) |
| "eighty-seven patients (age: 68 ± 10 years, 62% male) with heart failure [left ventricular ejection fraction (LVEF): 35% ± 13] underwent low-power intermittent MCE at rest and 2 min after dipyridamole infusion." | 3.77 | Coronary flow reserve assessed by myocardial contrast echocardiography predicts mortality in patients with heart failure. ( Anantharam, B; Bassett, P; Chahal, N; Hayat, S; Hickman, M; Janardhanan, R; Senior, R, 2011) |
| "A method for quantitative determination of the percentage of left ventricular myocardial 201Tl isotope uptake at rest and during dipyridamole test was first used in patients with dilated cardiomyopathy and coronary heart disease complicated by circulatory insufficiency or chronic myocarditis." | 3.68 | [The radionuclide diagnosis of dilated cardiomyopathy: a new approach to assessing myocardial perfusion function by 201Tl scintigraphic data at rest and during the performance of the dipyridamole test]. ( Belenkov, IuN; Naumov, VG; Ostroumov, EN; Saidova, MA; Sergienko, VB, 1992) |
| "The effects of dipyridamole, a coronary and peripheral vasodilator drug, on cardiac performance were investigated in nine patients with severe chronic heart failure." | 3.66 | Central hemodynamic effects of dipyridamole in severe heart failure: comparison with hydralazine. ( Gorlin, R; Medina, N; Meller, J; Packer, M, 1982) |
| "Data are reviewed describing hypoxemia, a newly identified feature in thalassemia." | 2.38 | Hypoxemia in thalassemia. ( Bunyaratvej, A; Chantaraksri, U; Fucharoen, S; Piankijagum, A; Siritanaratkul, N; Sonakul, D; Wasi, P; Winichagoon, P, 1992) |
| "Between 2008 and 2018, consecutive patients with HFrEF defined by left ventricular ejection fraction <40% prospectively referred for vasodilator stress perfusion CMR were followed for the occurrence of major adverse cardiovascular events (MACE), defined by cardiovascular death or nonfatal myocardial infarction." | 1.56 | Safety and Prognostic Value of Vasodilator Stress Cardiovascular Magnetic Resonance in Patients With Heart Failure and Reduced Ejection Fraction. ( Bonnet, G; Champagne, S; Claude Morice, M; Garot, J; Garot, P; Hovasse, T; Kinnel, M; Landon, V; Louvard, Y; Pezel, T; Sanguineti, F; Unterseeh, T, 2020) |
| "The heart transplant is a treatment of the heart failure, which is not responding to medications." | 1.37 | [Heart recruiment of elderly donors by pharmacological echostress]. ( Arpesella, G; Bombardini, T; Gherardi, S; La Falce, S; Picano, E, 2011) |
| "Adenosine is well known to be a cardioprotective substance in ischemic heart disease." | 1.34 | Impact of adenosine receptor signaling and metabolism on pathophysiology in patients with chronic heart failure. ( Asakura, M; Asanuma, H; Fujita, M; Furukawa, H; Isomura, T; Kim, J; Kitakaze, M; Komamura, K; Liao, Y; Nakamaru, K; Tomoike, H, 2007) |
| "Adverse cardiac events were defined as congestive heart failure (CHF), myocardial infarction (MI), unstable angina (USA), and ventricular arrhythmias." | 1.31 | An abnormal dipyridamole thallium/sestamibi fails to predict long-term cardiac events in vascular surgery patients. ( de Virgilio, C; Donayre, C; Elbassir, M; Ephraim, L; Toosie, K; Wall, DB; White, R, 2001) |
| "Arterial hypertension is the most common cause of congestive heart failure and an important risk factor in coronary artery disease (CAD)." | 1.28 | Coronary circulation in arterial hypertension. ( Motz, W; Scheler, S; Schwartzkopff, B; Strauer, BE; Vogt, M, 1991) |
| "Imipramine was infused at 1 mg/kg/min until cardiac failure and vascular collapse terminated the experiment at 21 +/- 2." | 1.27 | Treatment of haemodynamic and electrocardiographic side-effects resulting from imipramine toxicity in rats and dogs. ( Fiedler, VB; Göbel, H; Kettenbach, B; Nitz, RE, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 34 (52.31) | 18.7374 |
| 1990's | 8 (12.31) | 18.2507 |
| 2000's | 12 (18.46) | 29.6817 |
| 2010's | 10 (15.38) | 24.3611 |
| 2020's | 1 (1.54) | 2.80 |
| Authors | Studies |
|---|---|
| Pezel, T | 1 |
| Sanguineti, F | 1 |
| Kinnel, M | 1 |
| Landon, V | 1 |
| Bonnet, G | 1 |
| Garot, P | 1 |
| Hovasse, T | 1 |
| Unterseeh, T | 1 |
| Champagne, S | 1 |
| Louvard, Y | 1 |
| Claude Morice, M | 1 |
| Garot, J | 1 |
| Cortigiani, L | 2 |
| Ramirez, P | 1 |
| Coltelli, M | 1 |
| Bovenzi, F | 2 |
| Picano, E | 5 |
| Torres, MAR | 1 |
| Texeira, TF | 1 |
| Camarozano, AC | 1 |
| Bellagamba, CCA | 1 |
| Quevedo, NM | 1 |
| Junior, AIH | 1 |
| Bertoluci, C | 1 |
| Bombardini, T | 2 |
| De Nes, M | 1 |
| Ciampi, Q | 1 |
| Carpeggiani, C | 2 |
| Landi, P | 1 |
| Raciti, M | 1 |
| Del Ry, S | 2 |
| Morales, MA | 1 |
| Scali, MC | 1 |
| Tafi, A | 1 |
| Giustarini, C | 1 |
| Posteraro, F | 1 |
| Ambrosini, V | 1 |
| Agrusta, M | 1 |
| Sicari, R | 1 |
| Saeed, O | 1 |
| Shah, A | 1 |
| Kargoli, F | 1 |
| Madan, S | 1 |
| Levin, AP | 1 |
| Patel, SR | 1 |
| Jermyn, R | 1 |
| Guerrero, C | 1 |
| Nguyen, J | 1 |
| Sims, DB | 1 |
| Shin, J | 1 |
| D'Alessandro, D | 1 |
| Goldstein, DJ | 1 |
| Jorde, UP | 1 |
| Sandner, SE | 1 |
| Zimpfer, D | 1 |
| Zrunek, P | 1 |
| Steinlechner, B | 1 |
| Rajek, A | 1 |
| Schima, H | 1 |
| Wolner, E | 1 |
| Wieselthaler, GM | 1 |
| Nakata, T | 1 |
| Hashimoto, A | 1 |
| Wakabayashi, T | 1 |
| Kusuoka, H | 1 |
| Nishimura, T | 1 |
| van der Harst, P | 1 |
| Slart, RH | 1 |
| Tio, RA | 1 |
| Dunselman, PH | 1 |
| Willemsen, AT | 1 |
| van den Heuvel, AF | 4 |
| Voors, AA | 1 |
| van Veldhuisen, DJ | 4 |
| Giannessi, D | 1 |
| Caselli, C | 1 |
| Maltinti, M | 1 |
| Pardini, S | 1 |
| Turchi, S | 1 |
| Cabiati, M | 1 |
| Sampietro, T | 1 |
| Abraham, N | 1 |
| L'abbate, A | 2 |
| Neglia, D | 2 |
| Anantharam, B | 1 |
| Janardhanan, R | 1 |
| Hayat, S | 1 |
| Hickman, M | 1 |
| Chahal, N | 1 |
| Bassett, P | 1 |
| Senior, R | 1 |
| Lièvre, MM | 1 |
| Moulin, P | 1 |
| Thivolet, C | 1 |
| Rodier, M | 1 |
| Rigalleau, V | 1 |
| Penfornis, A | 1 |
| Pradignac, A | 1 |
| Ovize, M | 1 |
| La Falce, S | 1 |
| Arpesella, G | 1 |
| Gherardi, S | 1 |
| de Jong, RM | 1 |
| Blanksma, PK | 3 |
| Cornel, JH | 1 |
| Siebelink, HM | 1 |
| Vaalburg, W | 2 |
| Lund, GK | 2 |
| Watzinger, N | 2 |
| Saeed, M | 2 |
| Reddy, GP | 2 |
| Yang, M | 2 |
| Araoz, PA | 2 |
| Curatola, D | 1 |
| Bedigian, M | 2 |
| Higgins, CB | 2 |
| ROESELER, E | 1 |
| WOLF, H | 1 |
| SHALABY, ES | 1 |
| ABDELSALAM, R | 1 |
| KOBAYASHI, T | 1 |
| TAKEUCHI, M | 1 |
| OSHIMA, K | 1 |
| KUSHIRO, T | 1 |
| TAKAHASHI, S | 1 |
| FUJII, A | 1 |
| SASAKI, S | 1 |
| KIKUCHI, G | 1 |
| TAKAYAMA, T | 1 |
| KUWABARA, T | 1 |
| GRIEP, AH | 1 |
| DIAS, FO | 1 |
| FERREIRA, FG | 1 |
| NUNES, FC | 1 |
| RIOJA, DO | 1 |
| SILVA, FS | 1 |
| LEIBERMAN, A | 1 |
| GUGLIELMELLI, S | 1 |
| KOENIG, E | 1 |
| TREPEL, F | 1 |
| HOCHREIN, H | 1 |
| Schwartz, AB | 1 |
| Asakura, M | 1 |
| Asanuma, H | 2 |
| Kim, J | 1 |
| Liao, Y | 1 |
| Nakamaru, K | 1 |
| Fujita, M | 1 |
| Komamura, K | 1 |
| Isomura, T | 1 |
| Furukawa, H | 1 |
| Tomoike, H | 1 |
| Kitakaze, M | 2 |
| Sanada, S | 1 |
| Koretsune, Y | 1 |
| Watanabe, K | 1 |
| Nanto, S | 1 |
| Awata, N | 1 |
| Hoki, N | 1 |
| Fukunami, M | 1 |
| Hori, M | 1 |
| Marshall, AJ | 1 |
| Uberfuhr, P | 1 |
| Reichart, B | 1 |
| Welz, A | 1 |
| Kreuzer, E | 1 |
| Kemkes, BM | 1 |
| Klinner, W | 1 |
| Hammer, C | 1 |
| Ertel, W | 1 |
| Reichenspurner, H | 1 |
| Gokel, M | 1 |
| Land, W | 1 |
| Franke, N | 1 |
| Mathes, P | 1 |
| Pornin, M | 1 |
| Sellier, P | 1 |
| Lardoux, H | 1 |
| Duong, TC | 1 |
| Ourbak, P | 1 |
| Maurice, P | 1 |
| Burtsev, EM | 1 |
| Usov, LA | 1 |
| Atamaniuk, ED | 1 |
| Miller, LG | 1 |
| Held, K | 1 |
| Packer, M | 1 |
| Gorlin, R | 1 |
| Meller, J | 1 |
| Medina, N | 1 |
| Leshchinskiĭ, LA | 1 |
| Pimenov, LT | 1 |
| Trusov, VV | 1 |
| Ciliberto, GR | 1 |
| Massa, D | 1 |
| Mangiavacchi, M | 1 |
| Danzi, GB | 1 |
| Pirelli, S | 1 |
| Faletra, F | 1 |
| Frigerio, M | 1 |
| Gronda, E | 1 |
| De Vita, C | 1 |
| Stratmann, HG | 1 |
| Younis, LT | 1 |
| Wittry, MD | 1 |
| Amato, M | 1 |
| Miller, DD | 1 |
| Travin, MI | 1 |
| Duca, MD | 1 |
| Kline, GM | 1 |
| Herman, SD | 1 |
| Demus, DD | 1 |
| Heller, GV | 1 |
| Crijns, HJ | 2 |
| Fisher, C | 1 |
| Vehec, A | 1 |
| Kashlan, B | 1 |
| Longa, G | 1 |
| Houpt, L | 1 |
| Howe, K | 1 |
| Stark, L | 1 |
| Cavanaugh, D | 1 |
| de Virgilio, C | 1 |
| Wall, DB | 1 |
| Ephraim, L | 1 |
| Toosie, K | 1 |
| Donayre, C | 1 |
| White, R | 1 |
| Elbassir, M | 1 |
| Michelassi, C | 1 |
| Trivieri, MG | 1 |
| Sambuceti, G | 1 |
| Giorgetti, A | 1 |
| Pratali, L | 1 |
| Gallopin, M | 1 |
| Salvadori, P | 1 |
| Sorace, O | 1 |
| Poddighe, R | 1 |
| Parodi, O | 1 |
| Bax, JJ | 1 |
| Bøttcher, M | 1 |
| Refsgaard, J | 1 |
| Gøtzsche, O | 1 |
| Andreasen, F | 1 |
| Nielsen, TT | 1 |
| Hirano, T | 1 |
| Modica, G | 1 |
| Ferrante, R | 1 |
| Fucharoen, S | 1 |
| Winichagoon, P | 1 |
| Siritanaratkul, N | 1 |
| Sonakul, D | 1 |
| Chantaraksri, U | 1 |
| Bunyaratvej, A | 1 |
| Piankijagum, A | 1 |
| Wasi, P | 1 |
| Saidova, MA | 1 |
| Ostroumov, EN | 1 |
| Naumov, VG | 1 |
| Sergienko, VB | 1 |
| Belenkov, IuN | 1 |
| Motz, W | 1 |
| Vogt, M | 1 |
| Scheler, S | 1 |
| Schwartzkopff, B | 1 |
| Strauer, BE | 1 |
| Rechavia, E | 1 |
| Araujo, LI | 1 |
| De Silva, R | 1 |
| Kushwaha, SS | 1 |
| Lammertsma, AA | 1 |
| Jones, T | 1 |
| Mitchell, A | 1 |
| Maseri, A | 1 |
| Yacoub, MH | 1 |
| Chikamori, D | 1 |
| Hamashige, N | 1 |
| Odawara, H | 1 |
| Kusume, O | 1 |
| Furuno, T | 1 |
| Doi, Y | 1 |
| Ozawa, T | 1 |
| Cutler, BS | 1 |
| Nitenberg, A | 1 |
| Foult, JM | 1 |
| Blanchet, F | 1 |
| Zouioueche, S | 1 |
| Fiedler, VB | 1 |
| Kettenbach, B | 1 |
| Göbel, H | 1 |
| Nitz, RE | 1 |
| Bensaid, J | 1 |
| Gerbaux, A | 1 |
| Swan, H | 1 |
| Meagher, DM | 1 |
| Brendel, BS | 1 |
| Parratt, JR | 1 |
| Wadsworth, RM | 1 |
| Meessen, H | 1 |
| Ibarra-Pérez, C | 1 |
| Del Bosque-Ruiz, M | 1 |
| Lieberman, A | 1 |
| Itatsu, H | 1 |
| Schlosser, V | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The International Stress Echo Study to to Define the Future of Imaging[NCT05081115] | 10,000 participants (Anticipated) | Observational [Patient Registry] | 2021-04-01 | Recruiting | |||
| Randomized Strategy Trial Comparing Detection of Silent Ischemia With no Detection of Silent Ischemia in Asymptomatic Patients With Type 2 Diabetes Mellitus. Effects on Cardiovascular Events.[NCT00627783] | 642 participants (Actual) | Interventional | 2000-12-31 | Terminated (stopped due to Poor recruiting status) | |||
| Functional and Anatomic Imaging Versus No Testing in Asymptomatic High-risk Diabetic Patients[NCT04388280] | 400 participants (Anticipated) | Interventional | 2021-01-28 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for dipyridamole and Heart Failure
| Article | Year |
|---|---|
Detection of silent myocardial ischemia in asymptomatic patients with diabetes: results of a randomized trial and meta-analysis assessing the effectiveness of systematic screening.
Topics: Aged; Ambulatory Care; Asymptomatic Diseases; Cause of Death; Chi-Square Distribution; Diabetes Comp | 2011 |
Detection of silent myocardial ischemia in asymptomatic patients with diabetes: results of a randomized trial and meta-analysis assessing the effectiveness of systematic screening.
Topics: Aged; Ambulatory Care; Asymptomatic Diseases; Cause of Death; Chi-Square Distribution; Diabetes Comp | 2011 |
Detection of silent myocardial ischemia in asymptomatic patients with diabetes: results of a randomized trial and meta-analysis assessing the effectiveness of systematic screening.
Topics: Aged; Ambulatory Care; Asymptomatic Diseases; Cause of Death; Chi-Square Distribution; Diabetes Comp | 2011 |
Detection of silent myocardial ischemia in asymptomatic patients with diabetes: results of a randomized trial and meta-analysis assessing the effectiveness of systematic screening.
Topics: Aged; Ambulatory Care; Asymptomatic Diseases; Cause of Death; Chi-Square Distribution; Diabetes Comp | 2011 |
Drug therapy of hypertension and ischaemic heart disease.
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Antihypertensive Agents; Aspirin; Clofibrate; C | 1981 |
Hypoxemia in thalassemia.
Topics: Aspirin; Blood Gas Analysis; Dipyridamole; Follow-Up Studies; Heart Failure; Humans; Hypoxia; Platel | 1992 |
[Pathological anatomy in heart insufficiency].
Topics: Bronchodilator Agents; Dipyridamole; Endoplasmic Reticulum; Glycogen; Heart; Heart Failure; Humans; | 1967 |
7 trials available for dipyridamole and Heart Failure
| Article | Year |
|---|---|
Low molecular weight heparin as an alternative to unfractionated heparin in the immediate postoperative period after left ventricular assist device implantation.
Topics: Aged; Anticoagulants; Aspirin; Dipyridamole; Heart Failure; Heart-Assist Devices; Heparin; Heparin, | 2008 |
Effects of rosuvastatin on coronary flow reserve and metabolic mismatch in patients with heart failure (from the CORONA Study).
Topics: Aged; Aged, 80 and over; Biomarkers; C-Reactive Protein; Cholesterol, HDL; Cholesterol, LDL; Coronar | 2010 |
Detection of silent myocardial ischemia in asymptomatic patients with diabetes: results of a randomized trial and meta-analysis assessing the effectiveness of systematic screening.
Topics: Aged; Ambulatory Care; Asymptomatic Diseases; Cause of Death; Chi-Square Distribution; Diabetes Comp | 2011 |
Detection of silent myocardial ischemia in asymptomatic patients with diabetes: results of a randomized trial and meta-analysis assessing the effectiveness of systematic screening.
Topics: Aged; Ambulatory Care; Asymptomatic Diseases; Cause of Death; Chi-Square Distribution; Diabetes Comp | 2011 |
Detection of silent myocardial ischemia in asymptomatic patients with diabetes: results of a randomized trial and meta-analysis assessing the effectiveness of systematic screening.
Topics: Aged; Ambulatory Care; Asymptomatic Diseases; Cause of Death; Chi-Square Distribution; Diabetes Comp | 2011 |
Detection of silent myocardial ischemia in asymptomatic patients with diabetes: results of a randomized trial and meta-analysis assessing the effectiveness of systematic screening.
Topics: Aged; Ambulatory Care; Asymptomatic Diseases; Cause of Death; Chi-Square Distribution; Diabetes Comp | 2011 |
Long-term oral administration of dipyridamole improves both cardiac and physical status in patients with mild to moderate chronic heart failure: a prospective open-randomized study.
Topics: Aged; Dipyridamole; Dose-Response Relationship, Drug; Echocardiography; Exercise; Exercise Test; Fem | 2007 |
The Persantine-aspirin reinfarction study. The Persantine-aspirin Reinfarction Study (PARIS) research group.
Topics: Aspirin; Blood Pressure; Blood Urea Nitrogen; Cerebrovascular Disorders; Clinical Trials as Topic; C | 1980 |
Effect of carvedilol on microcirculatory and glucose metabolic regulation in patients with congestive heart failure secondary to ischemic cardiomyopathy.
Topics: Aged; Analysis of Variance; Blood Glucose; Carbazoles; Carvedilol; Catecholamines; Coronary Vessels; | 2002 |
Persantin.
Topics: Animals; Blood Circulation; Coronary Disease; Coronary Vessels; Dipyridamole; Heart Failure; Humans; | 1966 |
55 other studies available for dipyridamole and Heart Failure
| Article | Year |
|---|---|
Safety and Prognostic Value of Vasodilator Stress Cardiovascular Magnetic Resonance in Patients With Heart Failure and Reduced Ejection Fraction.
Topics: Aged; Contrast Media; Dipyridamole; Female; Heart Failure; Humans; Infusions, Intravenous; Longitudi | 2020 |
Drop-off in positivity rate of stress echocardiography based on regional wall motion abnormalities over the last three decades.
Topics: Adrenergic beta-1 Receptor Agonists; Aged; Coronary Artery Disease; Dipyridamole; Dobutamine; Echoca | 2019 |
The value of a simplified approach to end-systolic volume measurement for assessment of left ventricular contractile reserve during stress-echocardiography.
Topics: Adrenergic beta-1 Receptor Agonists; Aged; Coronary Artery Disease; Dipyridamole; Dobutamine; Echoca | 2019 |
Usefulness of Blunted Heart Rate Reserve as an Imaging-Independent Prognostic Predictor During Dipyridamole Stress Echocardiography.
Topics: Aged; Coronary Artery Disease; Dipyridamole; Dose-Response Relationship, Drug; Echocardiography, Str | 2019 |
Effect of concomitant oral chronic dipyridamole therapy on inflammatory cytokines in heart failure patients.
Topics: Cytokines; Dipyridamole; Female; Heart Failure; Humans; Inflammation Mediators; Male; Middle Aged; R | 2013 |
Antiplatelet Therapy and Adverse Hematologic Events During Heart Mate II Support.
Topics: Adult; Aged; Anticoagulants; Aspirin; Chi-Square Distribution; Dipyridamole; Disease-Free Survival; | 2016 |
Prediction of new-onset refractory congestive heart failure using gated myocardial perfusion SPECT imaging in patients with known or suspected coronary artery disease subanalysis of the J-ACCESS database.
Topics: Adenosine Triphosphate; Aged; Aged, 80 and over; Chronic Disease; Coronary Artery Disease; Coronary | 2009 |
Adiponectin is associated with abnormal lipid profile and coronary microvascular dysfunction in patients with dilated cardiomyopathy without overt heart failure.
Topics: Adiponectin; Ammonia; Body Mass Index; Cardiomyopathy, Dilated; Cholesterol, HDL; Cohort Studies; Co | 2011 |
Coronary flow reserve assessed by myocardial contrast echocardiography predicts mortality in patients with heart failure.
Topics: Aged; Chi-Square Distribution; Coronary Angiography; Coronary Circulation; Dipyridamole; Echocardiog | 2011 |
[Heart recruiment of elderly donors by pharmacological echostress].
Topics: Amyloidosis; Brain Death; Dipyridamole; Echocardiography, Stress; Echocardiography, Transesophageal; | 2011 |
Endothelial dysfunction and reduced myocardial perfusion reserve in heart failure secondary to coronary artery disease.
Topics: Aged; Case-Control Studies; Chronic Disease; Coronary Disease; Dipyridamole; Disease Progression; En | 2003 |
Chronic heart failure: global left ventricular perfusion and coronary flow reserve with velocity-encoded cine MR imaging: initial results.
Topics: Aged; Aged, 80 and over; Chronic Disease; Coronary Circulation; Dipyridamole; Female; Heart Failure; | 2003 |
[Clinical trials with persantin in the therapy of coronary and myocardial insufficiency].
Topics: Coronary Disease; Dipyridamole; Heart; Heart Failure; Myocardium; Vasodilator Agents | 1960 |
[On heart therapy with Persantin].
Topics: Cardiotonic Agents; Coronary Disease; Dipyridamole; Diuretics; Heart Failure; Vasodilator Agents | 1961 |
THE EFFECT OF 2, 6-BIS (DIETHANOLAMINO)-4,8-DIPIPERIDINE (PERSANTIN) ON THE PROTHROMBIN TIME.
Topics: Angina Pectoris; Dipyridamole; Heart Failure; Humans; Myocardial Infarction; Pharmacology; Phenindio | 1963 |
[REHABILITATION IN HEART DISEASE].
Topics: Acenocoumarol; Dipyridamole; Electrocardiography; Geriatrics; Heart Defects, Congenital; Heart Disea | 1963 |
[CLINICAL USE OF PERSANTIN].
Topics: Angina Pectoris; Dipyridamole; Electrocardiography; Heart Failure; Humans | 1963 |
NOCTURNAL ANGINA PECTORIS.
Topics: Angina Pectoris; Coronary Disease; Dipyridamole; Duodenal Obstruction; Heart Failure; Heart Valve Di | 1964 |
[OUR CLINICAL EXPERIENCE WITH A NEW SUBSTANCE OF THE PYRIMIDO-PYRIMIDINE GROUP IN THE TREATMENT OF CORONARY (AND CARDIAC) INSUFFICIENCY].
Topics: Coronary Disease; Dipyridamole; Geriatrics; Heart Failure; Pyrimidines | 1964 |
PERSANTIN-- A DOUBLE BLIND STUDY.
Topics: Biomedical Research; Coronary Disease; Dipyridamole; Double-Blind Method; Drug Therapy; Geriatrics; | 1964 |
[CLINICO-EXPERIMENTAL STUDIES ON THE POSITIVE INOTROPIC EFFECT OF PERSANTIN].
Topics: Biomedical Research; Blood Pressure; Coronary Disease; Digitalis Glycosides; Dipyridamole; Drug Ther | 1964 |
[ON THE ENERGY-, ELECTROLYTE- AND ENZYME METABOLISM OF THE HYPOXIC HEART].
Topics: Dipyridamole; Electrolytes; Heart; Heart Failure; Humans; Lactates; Metabolism; Myocardium; Oxidored | 1964 |
Myocardial blood flow in patients with dilated cardiomyopathy: quantitative assessment with velocity-encoded cine magnetic resonance imaging of the coronary sinus.
Topics: Adult; Aged; Cardiomyopathy, Dilated; Coronary Circulation; Dipyridamole; Female; Heart Failure; Hum | 2005 |
Impact of adenosine receptor signaling and metabolism on pathophysiology in patients with chronic heart failure.
Topics: Adenosine; Adult; Aged; Chronic Disease; Dipyridamole; Female; Gene Expression; Gene Expression Prof | 2007 |
[Report on a successful orthotopic cardiac transplantation in Germany].
Topics: Adrenal Cortex Hormones; Adult; Antilymphocyte Serum; Azathioprine; Creatinine; Cyclosporins; Dipyri | 1982 |
[Coronary hemodynamics and myocardial metabolism in primary dilated-type myocardiopathy].
Topics: Adult; Aged; Cardiomyopathies; Coronary Disease; Coronary Vessels; Dipyridamole; Electric Stimulatio | 1980 |
[Experimental and clinical study of the efficacy of intracarotid administration of curantil in the treatment of cerebral ischemia].
Topics: Adult; Animals; Brain; Brain Ischemia; Carotid Artery, Internal; Catheterization; Cats; Cerebral Inf | 1983 |
[Conservative therapy of stroke from an internist's viewpoint].
Topics: Anticoagulants; Aspirin; Cerebrovascular Disorders; Digitalis Glycosides; Dipyridamole; Diuretics; H | 1983 |
Central hemodynamic effects of dipyridamole in severe heart failure: comparison with hydralazine.
Topics: Administration, Oral; Aged; Dipyridamole; Drug Evaluation; Female; Heart Failure; Hemodynamics; Huma | 1982 |
[Changes in renal hemodynamics and renal function in patients with cardiac insufficiency treated with vasodilators].
Topics: Bencyclane; Dipyridamole; Heart Failure; Humans; Kidney; Papaverine; Renal Circulation; Vasodilator | 1981 |
High-dose dipyridamole echocardiography test in coronary artery disease after heart transplantation.
Topics: Adult; Coronary Angiography; Coronary Disease; Dipyridamole; Echocardiography; Female; Follow-Up Stu | 1993 |
Dipyridamole technetium-99m sestamibi myocardial tomography in patients evaluated for elective vascular surgery: prognostic value for perioperative and late cardiac events.
Topics: Aged; Dipyridamole; Heart Failure; Humans; Intraoperative Complications; Male; Myocardial Infarction | 1996 |
Relation of gender to physician use of test results and to the prognostic value of stress technetium 99m sestamibi myocardial single-photon emission computed tomography scintigraphy.
Topics: Angina Pectoris; Angina, Unstable; Cardiac Catheterization; Coronary Disease; Death, Sudden, Cardiac | 1997 |
Ischemia and left ventricular dysfunction: a reciprocal relation?
Topics: Adult; Blood Flow Velocity; Coronary Disease; Dipyridamole; Female; Fluorodeoxyglucose F18; Heart Fa | 1998 |
Incidental detection of skeletal uptake on sestamibi cardiac images in a patient with previously undiagnosed multiple myeloma.
Topics: Aged; Aged, 80 and over; Bone and Bones; Dipyridamole; Female; Heart; Heart Failure; Humans; Multipl | 2000 |
An abnormal dipyridamole thallium/sestamibi fails to predict long-term cardiac events in vascular surgery patients.
Topics: Aged; Aortic Diseases; Cause of Death; Dipyridamole; Female; Follow-Up Studies; Heart Failure; Human | 2001 |
Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction.
Topics: Coronary Circulation; Dipyridamole; Disease Progression; Disease-Free Survival; Female; Follow-Up St | 2002 |
Abnormalities in myocardial contractility, metabolism and perfusion reserve in non-stenotic coronary segments in heart failure patients.
Topics: Aged; Case-Control Studies; Coronary Angiography; Coronary Circulation; Coronary Disease; Dipyridamo | 2002 |
[Physiology and pharmacology related to cardiac resuscitation (2)].
Topics: Animals; Catecholamines; Coronary Circulation; Dipyridamole; Dogs; Heart Failure; Resuscitation; Xan | 1976 |
[Clinical and experimental results of treatment with amiodarone in coronary insufficiency].
Topics: Aged; Amiodarone; Angina Pectoris; Arrhythmias, Cardiac; Benzofurans; Coronary Disease; Dipyridamole | 1975 |
[The radionuclide diagnosis of dilated cardiomyopathy: a new approach to assessing myocardial perfusion function by 201Tl scintigraphic data at rest and during the performance of the dipyridamole test].
Topics: Adolescent; Adult; Aged; Cardiomyopathy, Dilated; Chronic Disease; Dipyridamole; Electrocardiography | 1992 |
Coronary circulation in arterial hypertension.
Topics: Animals; Coronary Circulation; Dipyridamole; Heart Failure; Humans; Hypertension; Middle Aged; Rats; | 1991 |
Dipyridamole vasodilator response after human orthotopic heart transplantation: quantification by oxygen-15-labeled water and positron emission tomography.
Topics: Adult; Coronary Circulation; Dipyridamole; Heart Failure; Heart Transplantation; Humans; Infusions, | 1992 |
[A case of severe cardiac failure due to myocardial stunning].
Topics: Coronary Angiography; Dipyridamole; Heart; Heart Failure; Humans; Middle Aged; Myocardial Infarction | 1989 |
Prevention of cardiac complications in peripheral vascular surgery.
Topics: Angiography; Arrhythmias, Cardiac; Cerebrovascular Disorders; Coronary Disease; Dipyridamole; Electr | 1986 |
Multifactorial determinants of reduced coronary flow reserve after dipyridamole in dilated cardiomyopathy.
Topics: Adult; Blood Flow Velocity; Blood Pressure; Cardiac Catheterization; Cardiomyopathy, Dilated; Corona | 1985 |
Treatment of haemodynamic and electrocardiographic side-effects resulting from imipramine toxicity in rats and dogs.
Topics: Animals; Arrhythmias, Cardiac; Chromonar; Coumarins; Dipyridamole; Dogs; Electrocardiography; Female | 1985 |
[Late dysfunction of mitral valve prosthesis due to thrombosis. Its detection and the practical attitude required].
Topics: Aged; Amplifiers, Electronic; Anticoagulants; Cardiac Catheterization; Dipyridamole; Electrocardiogr | 1974 |
Total body bypass in miniature pigs. Postperfusion pulmonary hypertension.
Topics: Acidosis; Anesthesia, Inhalation; Animals; Blood Group Incompatibility; Blood Pressure; Capillary Pe | 1971 |
[Cardiovascular complications in operated patients more than 70 years old suffering from cardiovascular insufficiency].
Topics: Age Factors; Aged; Aminophylline; Anesthesia, General; Aspartic Acid; Cardiac Surgical Procedures; D | 1972 |
The effects of dipyridamole on coronary post-occlusion hyperaemia and on myocardial vasodilatation induced by systemic hypoxia.
Topics: Animals; Benzoates; Blood Pressure; Catheterization; Cats; Coronary Vessels; Dipyridamole; Electroca | 1972 |
Pregnancy in 6 patients with Starr-Edwards heart valve prostheses.
Topics: Abortion, Threatened; Acenocoumarol; Adult; Dipyridamole; Extraction, Obstetrical; Female; Follow-Up | 1972 |
The case of the Zapista from Durango.
Topics: Aged; Dipyridamole; Heart Failure; Humans; Male | 1970 |
On the factors which affect the immediate and long-term prognosis of myocardial infarction.
Topics: Adult; Age Factors; Aged; Angina Pectoris; Blood Pressure; Diabetes Complications; Dipyridamole; Ele | 1967 |
[Immediate postischemic sufficiency of the warm-blooded heart and its pharmacologic control].
Topics: Animals; Blood Pressure Determination; Cardiac Surgical Procedures; Dipyridamole; Dogs; Heart Failur | 1965 |